Shandong Weigao Orthopaedic Device Co. Ltd. A - Asset Resilience Ratio

Latest as of March 2026: 6.28%

Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) has an Asset Resilience Ratio of 6.28% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥325.88 Million
≈ $47.69 Million USD Cash + Short-term Investments

Total Assets

CN¥5.19 Billion
≈ $759.56 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how Shandong Weigao Orthopaedic Device Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688161 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Shandong Weigao Orthopaedic Device Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Shandong Weigao Orthopaedic Device Co. L.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥325.88 Million 6.28%
Total Liquid Assets CN¥325.88 Million 6.28%

Asset Resilience Insights

  • Limited Liquidity: Shandong Weigao Orthopaedic Device Co. Ltd. A maintains only 6.28% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shandong Weigao Orthopaedic Device Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shandong Weigao Orthopaedic Device Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sinocare Inc
SHE:300298
Medical Devices 3.53%
T&R Biofab Co. Ltd
KQ:246710
Medical Devices 0.12%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM
Medical Devices 46.67%
Allmed Solutions Ltd
TA:ALMD
Medical Devices 80.03%
Universal Biosensors Inc
AU:UBI
Medical Devices 14.72%
EBR Systems Inc
AU:EBR
Medical Devices 54.70%
Cochlear Ltd
AU:COH
Medical Devices 9.76%

Annual Asset Resilience Ratio for Shandong Weigao Orthopaedic Device Co. Ltd. A (2021–2025)

The table below shows the annual Asset Resilience Ratio data for Shandong Weigao Orthopaedic Device Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 6.05% CN¥306.15 Million
≈ $44.80 Million
CN¥5.06 Billion
≈ $740.59 Million
+4.22pp
2024-12-31 1.83% CN¥90.54 Million
≈ $13.25 Million
CN¥4.95 Billion
≈ $724.05 Million
+1.64pp
2021-12-31 0.19% CN¥10.00 Million
≈ $1.46 Million
CN¥5.40 Billion
≈ $790.67 Million
--
pp = percentage points

About Shandong Weigao Orthopaedic Device Co. Ltd. A

SHG:688161 China Medical Devices
Market Cap
$1.26 Billion
CN¥8.61 Billion CNY
Market Cap Rank
#7905 Global
#1798 in China
Share Price
CN¥21.52
Change (1 day)
-1.28%
52-Week Range
CN¥20.15 - CN¥36.64
All Time High
CN¥104.04
About

Shandong Weigao Orthopaedic Device Co., Ltd. engages in research, development, production, and sales of orthopedic medical devices. The company offers orthopedic implantable medical devices and orthopedic surgical instruments. It also provides spinal products, such as internal fixation systems for the cervical and thoracic/lumbar spine, and interbody fusion devices; trauma-related products includ… Read more